Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.
2.

Pharmacokinetic changes of oral sulfamethoxazole in rabbits with diabetes mellitus induced by alloxan.

Choi JS, Choi BC.

Res Commun Mol Pathol Pharmacol. 2000 Nov-Dec;108(5-6):332-40.

PMID:
11958286
3.

Pharmacokinetic and pharmacodynamic changes of furosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus.

Park JH, Lee WI, Yoon WH, Park YD, Lee JS, Lee MG.

Biopharm Drug Dispos. 1998 Sep;19(6):357-64.

PMID:
9737816
4.
7.
8.

A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects.

Roux A, Henry JF, Fouache Y, Chau NP, Hervy MP, Forette F, Bourdarias JP, Flouvat B.

Gerontology. 1983;29(3):202-8.

PMID:
6852547
9.
10.

Pharmacokinetic changes of M1, M2, M3, and M4 after intravenous administration of a new anthracycline, DA-125, to alloxan-induced diabetes mellitus rats.

Choi YJ, Lee HJ, Kwon JW, Kim WB, Yang J, Lee MG.

Res Commun Mol Pathol Pharmacol. 1996 Nov;94(2):181-92.

PMID:
8987115
12.

Pharmacokinetics and multiple peaking of acebutolol enantiomers in rats.

Piquette-Miller M, Jamali F.

Biopharm Drug Dispos. 1997 Aug;18(6):543-56.

PMID:
9267686
13.

The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).

Gulaid AA, James IM, Kaye CM, Lewellen OR, Roberts E, Sankey M, Smith J, Templeton R, Thomas RJ.

Biopharm Drug Dispos. 1981 Apr-Jun;2(2):103-14.

PMID:
7248475
14.

Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.

Bae SK, Kim JY, Yang SH, Kim JW, Kim T, Lee MG.

Life Sci. 2006 Apr 11;78(20):2287-94. Epub 2005 Nov 8.

PMID:
16288785
15.

Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.

Bae SK, Lee SJ, Kim YG, Kim SH, Kim JW, Kim T, Lee MG.

Biopharm Drug Dispos. 2005 Apr;26(3):99-115.

PMID:
15723427
17.

Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus.

Zhao C, Vaidyanathan S, Yeh CM, Maboudian M, Armin Dieterich H.

Clin Pharmacokinet. 2006;45(11):1125-34.

PMID:
17048976
18.

Pharmacokinetics and ocular disposition of paracetamol and paracetamol glucuronide in rabbits with diabetes mellitus induced by alloxan.

Bienert A, Kamińska A, Olszewski J, Gracz J, Grabowski T, Wolc A, Grześkowiak E.

Pharmacol Rep. 2012;64(2):421-7.

19.

The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.

Zhang SQ, Zhong XY, Chen GH, Lu WL, Zhang Q.

J Pharm Pharmacol. 2008 Jan;60(1):99-105.

PMID:
18088510
20.

Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.

Ahn CY, Bae SK, Jung YS, Lee I, Kim YC, Lee MG, Shin WG.

Drug Metab Dispos. 2008 Jul;36(7):1233-41. doi: 10.1124/dmd.107.017442. Epub 2008 Mar 31.

Supplemental Content

Support Center